Orphazyme

Orphazyme is a biopharmaceutical company pioneering the use of the heat shock protein response to treat neurodegenerative orphan diseases. Orphazyme is leveraging the amplification of heat shock proteins (or HSP) to develop and commercialize novel therapies for severe diseases, including lysosomal storage disorders and neuromuscular degenerative conditions.